Renalytix plc (RNLX) - Year-over-year earnings per share growth for the last twelve months

Renalytix, plc - graphic logo of issuer RNLX

Renalytix Plc (RNLX) is implementing AI systems for the preemptive detection of renal pathologies. Low geopolitical risks and access to developed markets guarantee business stability. High demand for diagnostics provides the company with pricing power. The history of quarterly EPS growth demonstrates real operational efficiency, where 0.00 shows the current volume of the metric on this chart.

Renalytix AI (RNLX) - Earnings per share growth in annualized terms for the last twelve months from 07/04/2022 to 10/19/2024

renalytix.com (RNLX) - metric breakdowns and financial figures

- share price and expert price forecast:
- market capitalization indicators:
Comprehensive company analysis:Renalytix Plc
Manufactured product of Renalytix Plc

The slow adoption of AI diagnostics and challenges with insurance coverage create a liquidity shortage risk for Renalytix Plc (RNLX). By analyzing quarter-over-quarter EPS dynamics, an investor can observe the mathematical change in net income per share, which allows them to filter out market noise and assess the real pressure of operating expenses on final margins and the business's market value.